Cervical cancer is one of the most common gynecological cancers worldwide. Over the past decade, much progress has been made in understanding the genetic changes associated with the development and progression of cervical cancer. However, the precise mechanisms of cervical carcinogenesis in Uigur women remain unclear. To screen differential gene expression in squamous cell carcinoma (SCC) of the cervix in Uigur women, suppressive subtractive hybridization (SSH) was performed on the cervical squamous cell carcinoma and corresponding normal cervical tissues of a Uigur patient. Thus we were be able to find the genes that are related with cervical tumors of Uigur women. A total of 300 samples were subject to DNA sequencing analysis and 46 genes were found to express differentially in tumors compared with normal tissues. Of the 46 genes, 24 genes were up-regulated whereas 22 genes were down-regulated in cervical tumors. The expression profiles of 5 of the 46 genes were further confirmed in 15 other Uigur patients by semi-quantitative reverse-transcription polymerase chain reaction. Our results revealed that ACADVL, CEBPB, IFITM1 and DNAJC9 are involved in cervical carcinogenesis.
tissues and their corresponding normal cervical tissues. We chose two up-regulated genes and three down-regulated genes in tumor cells that were involved in apoptosis or proliferation of cells, as detected by SSH analysis. These five differentially expressed genes were investigated in 15 cervical tumor tissue samples and normal cervical tissues. The differences in the expression of these genes provide clues to further understand the specificity of cervical carcinogenesis in Uigur women.
Materials and methods

Clinical sample collection.
Sixteen patients with cervical squamous cell carcinoma were surgically treated in the First Affiliated Hospital and the Third Affiliated Hospital of the Medical College of Shihezi University, Xinjiang, China. None of these patients received chemotherapy or radiotherapy before the cervical tissues were obtained. All histological diagnoses were confirmed by experienced pathologists. Approval was obtained from the ethics committees of the First Affiliated Hospital and the Third Affiliated Hospital, Medical College of Shihezi University. The tumor tissues and their paired morCervical cancer is the most common gynecological malignancy worldwide and is one of the most common cancers diagnosed in women [1] . It is important to determine the mechanisms that are involved in cervical carcinogenesis. Over the past decade, much progress has been made in understanding the genetic changes associated with development and progression of cervical cancer. For example, it is now clear that the H-ras, N-ras and LAMP3 genes are activated in cervical tumors, whereas KAI1 and galectin-3 genes are inactivated [2, 3, 4, 5] . In addition, it was found that the retinoic acid receptor beta gene is down-regulated in cervical tumors, whereas a gene for telomerase reverse transcriptase is up-regulated [6, 7] . We found that the promoter of RASSF1A gene was methylated in squamous cervical carcinoma of Uigur women [8] . The precise mechanisms of cervical carcinogenesis in Uigur women, however, remains unclear and it is likely that more genes are involved in this type of cervical carcinogenesis.
Using a combination of suppressive subtractive hybridization (SSH) and semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR), we investigated the genes that were differentially expressed between this Uigur cervical tumor phologically normal cervical tissues or adjacent cervical tissue were placed in liquid nitrogen immediately after resection from the patients and stored in liquid nitrogen until use.
Sample preparation. The 16 pairs of tumor tissue and normal cervical tissue that were surgically removed were immediately examined by a gynecologic pathologist (Table 1) . Two or three pieces (5×5 mm) of tumor tissue from the periphery of the tumor mass were immediately stored in liquid nitrogen until use. The normal cervical tissues were sampled approximately 1.5 cm away from the primary lesion and were confirmed by examination of the H&E slides of the tissue samples. The 16 pairs of cervical tumor tissue samples and corresponding normal cervical tissue samples were transported to laboratory immediately after surgery for RNA extraction. All tumor samples were determined to contain at least 70% tumor cellularity by H&E staining.
One sample of cervical tumor tissue and its corresponding normal tissue sample were used to construct the SSH library; the other 15 The tester and driver cDNAs were digested with the restriction enzyme Rsa1. The tester cDNA was then divided into two portions and each was ligated with a different cDNA adaptor, which resulted in two populations of tester-adaptor cDNA. An excess of driver cDNA was added to each sample of tester cDNA for the first hybridization. The mixed testerdriver samples were heat-denatured and allowed to re-anneal. The two primary hybridization samples were then mixed with new driver cDNA, allowed to hybridize, and then subjected to PCR amplification. Products from the secondary PCRs were inserted into pMD19-T vectors (Takara Biotechnology, Japan) and then analyzed by DNA sequencing. We confirmed the differential expression of the subtracted clones with the PCRselect Differential Screening Kit (Clontech, USA) according to the manufacturer's instruction.
Sequencing and homology search. Plasmids used in DNA sequencing were purified with the Qiaprep Mini Plasmid Kit (Qiagen), according to the manufacturer's instruction. Cycle sequencing was performed in a 10-µl reaction mix using PRISM BigDye terminator mix (Applied Biosystems, Shanghai, China) according to the manufacturer's instruction. The sequences generated were searched for homologous sequences in the National Centre for Biotechnology Information (NCBI) database with the program BLASTn.
Semi-quantitative reverse transcription polymerase chain reaction analysis. Total RNA was extracted from 15 pairs of cervical tumor samples and adjacent normal cervical tissue samples, and then reverse transcribed to cDNA using SuperScript II reverse transcriptase (Invitrogen, USA) in a 20-ul reaction. PCR assays were performed in 25-µl reactions; each reaction contained 100 µM of each deoxynucleotide triphosphate, 2 mM of MgCl2, 10 pmol of each primer and 0.5 U Taq polymerase (Takara Biotechnology, Japan). The PCR conditions were: 94°C for 2 minutes; 35 cycles of 94°C for 30 seconds, 60°C for 30 seconds, and 72°C for 30 seconds; followed by 5 minutes at 72°C. GAPDH was used as an internal control in each PCR reaction. We selected five genes that were involved in apoptosis or proliferation of cells to examine the expression levels of mRNA. The PCR primers for individual genes were designed and analyzed using the program Primer3 (http://www.genome.wi.mit. edu/cgi-bin/primer/primer3_www.cgi; Table 2 ). All primers were synthesized by Sangon Ltd (Shanghai, China). PCR products were analyzed by 1.5% agarose-gel electrophoresis. The gel images were obtained with a CCD camera (Bio-Rad Laboratories, USA); the band intensity was calculated using Quantity One 4.1 applied software. Each pair of tumor and normal tissue samples was normalized to the expression level of GAPDH in the same sample.
Results
The two SSH cDNA libraries were generated from a cervical tumor tissue sample and a normal cervical tissue sample of one Uigur patient. We sequenced 150 clones from the up-regulated library and 150 clones from the down-regulated library. The sequences were aligned against the GenBank database and any redundant or false-positive sequences were excluded. A total of 46 non-redundant transcripts were found, of which 24 were genes known to be expressed at high levels in cervical tumors and 22 were genes known to be expressed at low levels in cervical tumors. BLAST analysis found genes in GenBank that had more than 95% homology to the cDNAs we sequenced (Tables 3 and 4) .
We chose five of the 46 differentially expressed genes for validation by semi-quantitative RT-PCR in 15 pairs of Uigur women cervical tumor tissues and the their cervical normal tissue samples. The low rates of false-positive results indicated that the two SSH libraries were effective for analysis of the five differential expression genes. We found that two genes (DNAJC9 and CD44) were up-regulated in cervical tumor tissues. In addition, the expression of three genes (ACADVL, CEBPB and IFITM1) was repressed in cervical tumor tissues ( Figure 1 ).
Discussion
It was reported that KRT8 gene was over-expressed in HPV positive cervical carcinoma [9] . This is similar to what we found in this study by SSH. Using microarray method, Grigsby et al. found that PTPRM and LAPTM4B gene were up-regulated in cervical cancer and ELF4 and DOCK2 genes NM_005194  NM_001442  NM_000993  NM_001023  NM_003641  NM_017866  NM_152855  NM 000967  NM_000989  NM_001000  XR_016460  NM_016321  NM_000599  NM_002432  NM_004364  NM_003291  NM_001793  NM_015881  NM_006192  NM_006536  NM_005854 17p13 Table 1 . RT-PCR with a GAPDH primer was performed as a control. Images obtained were processed for quantitative analysis using the Quantity One 4.1 applied software. The relative quantities of the specific PCR products were determined by densitometry and standardized to the GAPDH level in the same sample.
were down-regulated in cervical cancer [10] . In addition, SDHB gene was up-regulated and IFN-γ gene was downregulated in lymph node metastasis of cervical carcinoma by microarray [11] .
Our results showed that 24 genes were up-regulated whereas 22 genes were down-regulated in cervical tumors of Uigur women. These differentially expressed genes encode ribosomal proteins (RPL31, RPL26), a metabolism enzyme (ACADVL), a protein responsible for cell-cell interactions (KRT8), a protein responsible for cell adhesion and migration (CD44), a transcription factor (CEBPβ) and a translation elongation factor (EEF1A1).
To validate the differentially expressed genes identified by the SSH method, two up-regulated genes and three down-regulated genes were selected and further screened by semi-quantitative RT-PCR analysis. Among the five genes tested, the up-regulation of DNAJC9 and CD44 and downregulation of ACADVL, CEBPB and IFITM1 were consistent with the expression profiles obtained from SSH analysis. The finding that the CD44 gene is up-regulated in cervical tumors and is rarely expressed in normal tissues is in agreement with the results of previous research [12] . However, to our knowledge, the expression profiles of the ACADVL, CEBPB, IFITM1 and DNAJC9 genes in cervical tumors of Uigur women have not been reported previously.
Of the up-regulated genes, DNAJC9 is a member of the Hsp40 gene family. Hsp40 contains a DnaJ domain; Hsp40 and GrpE protein are co-chaperones that assist Hsp70. Hsp70 proteins are universally conserved ATP-dependent molecular chaperones that help proteins to adopt and maintain their native conformations [13] . Many proteins contain DnaJ domains that can participate in endocytosis and protect cells from various stresses. A DnaJ/Hsp40 homolog has been found to be up-regulated in human leukemia Molt-4 cells treated with nonthermal low-intensity-pulsed ultrasound [14] . The DNAJC9 gene may be up-regulated to protect cells from apoptosis in these cervical tumors.
Of the three down-regulated genes, ACADVL is a member of the family of multimeric enzymes that catalyze the alpha, beta-dehydrogenation of acyl-CoA esters in fatty-acid betaoxidation and amino-acid catabolism [15] . The ACADVL gene has recently been reported to be significantly down-regulated in adrenocortical carcinomas [16] . It is possible that the ACADVL gene has a role in development of cervical tumors in Uigur women.
The CEBPB gene is known to be down-regulated in hepatoblastoma cells. Expression of CEBPB proteins may have an important role in the genesis of hepatoblastoma cells, probably by inducing different stages of arrest of differentiation [17] . It is likely that the CEBPB gene is involved in differentiation of these cervical tumors.
Interferon-induced trans-membrane protein 1 (IFITM1) has a key role in the anti-proliferative action of IFN-gamma and cell-adhesion signals. Suppression of IFITM1 has been shown to block the anti-proliferative effect of IFN-gamma, accelerate the cell growth rate and confer tumorigenicity to a non-malignant hepatocyte cell line in nude mice [18] . IFITM1 is a component of a multimeric complex involved in the transduction of anti-proliferative signals. It has been reported that IFITM1 expression is significantly different between patients classed as being at high or low risk of chronic myeloid leukemia. In addition, higher levels of IFITM1 expression are associated with improved survival [19] . It is likely that low-level expression of the IFITM1 gene is associated with a high proliferative status of Uigur women cervical tumors.
In summary, we identified 46 genes that were differentially expressed between cervical tumor tissues and normal cervical tissues in Uigur patients. The expression profiles of 5 of these 46 genes were further confirmed in 15 other Uigur cervical tumor patients by semi-quantitative reverse-transcription polymerase chain reaction. The CD44 and KRT8 genes have previously been reported to be associated with cervical tumors, yet their roles in cervical tumors need to be further investigated. However, four other genes shown to be differentially expressed by the semi-quantitative RT-PCR analysis have not been previously associated with cervical tumors. Further characterization of these differentially expressed genes will help us to understand the role of genes responsible for the development of Uigur women cervical tumors.
